Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/da05e924-2410-4fdc-ae9c-7a87bb611124/

INCY

Incyte Corporation
Chart
$102.38
Latest Week 2026-06-05
HealthcareBiotechnologyLARGE
Snapshot 2026-06-07 · 0.0w · Fresh
0.72
OS Score
31.0%
Value
96.0%
Quality
83.0%
Momentum
7/9
F-Score
0.546
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
6 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
P/E 14.8
◇
VC2 Cheapest
✗
📐
EBITDA/EV
10.6%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
ROE 26%
📈
Consistent Earners
✗
🌱
GARP
Rev +21%
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
12-1 43%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
RAM 1.39
V
Value Analysis
Cheapness relative to fundamentals
31.0%ile
P/E
14.8×
P/S
3.9×
P/B
3.8×
E/P
0.0676
FCF Yield
0.089
EBITDA/EV
0.106
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
73.00000000
/100 — 1=cheapest
VC2 (Trending Value)
81.00000000
/100
VC3 (Buyback)
81.00000000
/100
FCF yield of 8.9% is strong — the business generates significant free cash relative to price. VC2 score of 81.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
96.0%ile
ROE
0.258
ROA
0.195
Net Margin
0.267
Op Margin
0.331
GPA
0.676
D/E
0.32
Current
3.68
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.215
Stability
1.524
lower=better
Accruals
-0.012
lower=better
5yr Consist
No
ROE of 26% is exceptional. Conservative balance sheet with D/E of 0.32.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
83.0%ile
6M Return
-0.1%
12M Return
48.9%
12-1 Mom
43.3%
Risk-Adj
1.39
Vol 252d
31.2%
Vol 60d
70.5%
↑ Expanding
Max DD 12M
-16.7%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 43% is very strong — a clear uptrend. Near-term vol (70%) is expanding vs long-term (31%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.72
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
9.0%
Sector Quality %ile
96.8%
P/E z-score
-0.19
P/B z-score
-0.10
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Growth at Reasonable Price
Revenue growing 21% with P/E of 15×. Growth isn't fully priced in.
Quality Momentum — Expensive
Strong quality (96th) and momentum (83th) but expensive (31th value). Premium priced — watch for mean reversion.
Volatility Expanding
60-day vol (70%) significantly exceeds 252-day (31%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
56.6% avg (7 factors)
Quality
A
91.0% avg (8 factors)
Momentum
B
68.9% avg (4 factors)
Risk
B
64.7% avg (1 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.720—1—
Value %ile0.310—0—
Quality %ile0.960—1—
Momentum %ile0.830—1—
F-Score7.000—1—
Confidence1.000—1—
Volatility0.312—0—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
14.79
Earnings Yield (E/P)
0.0676
Price / Sales
3.95
Price / Book
3.81
Price / Cash Flow
13.96
FCF Yield
8.9%
EBITDA / EV
10.6%
Sales Yield (1/P·S)
0.3026
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
25.8%
Return on Assets
19.5%
Net Margin
26.7%
Operating Margin
33.1%
Gross Profit / Assets
Novy-Marx GPA
67.6%
Debt / Equity
0.32
Current Ratio
3.68
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.012
MomentumPrice trend strength over different horizons
6M Return
-0.1%
12M Return
48.9%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
43.3%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
1.39
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
21.5%
Earnings Stability (CV)
Lower = more stable
1.524
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
7
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
73
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
81
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
81
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity